Every life sciences hiring leader has a mental list of the roles they dread reopening. Biostatistician and regulatory affairs specialist are almost always on it — not because these roles are obscure, but because the people qualified to fill them are being pulled in more directions than the industry has candidates to spare.
How much longer do biostatistics roles actually stay open?
Considerably longer than comparable data roles. Biostatistics postings had a 34-day median time-open versus 20 days for general data science roles in the same pharma dataset (PharmaPayWatch). That's a 70% longer open period for a role that, on paper, sits in the same broad talent category as general data science — evidence that the skill requirement is narrower and the qualified pool is thinner than the job-title similarity suggests.
Why do employers keep naming these two functions as hardest to source?
Because both require a rare combination of technical depth and regulatory fluency that doesn't map cleanly to a standard degree path. Industry HR leaders continue to rank regulatory affairs/compliance and computational biology/biostatistics among the hardest roles to source, even as overall hiring difficulty eases from 2021-22 peaks (TEConomy/InnovateBio 2025 Life Sciences Workforce Trends Report).
Is demand for these skills actually growing?
Yes, and faster than the industry's overall footprint. Life sciences data scientist roles grew 22% since 2022 and are nearly twice as concentrated in the industry as the national average (TEConomy/InnovateBio). Employers describe an “acute shortage of trained biostatisticians and data scientists… not being created enough by our institutions” — a supply-side constraint that predates and compounds any demand growth (TEConomy/InnovateBio).
Where is the trained talent actually going, if not into biotech?
A meaningful share is migrating to big tech. Industry commentary notes that when biostatisticians and computational biologists are trained, “they're oftentimes migrating towards the tech sector, and away from the biotech sector” (TEConomy/InnovateBio 2025). This means the competition for these specific skill sets isn't just cross-company within biotech — it's cross-industry, against employers who can often offer more standardized compensation structures and faster hiring processes.
How does geographic concentration make this specific gap worse?
Because the specialists who remain in the sector are clustered in the same few hubs as every competitor. Massachusetts alone accounts for 117,108-143,224 biopharma/life-sciences jobs and represents 23% of the entire U.S. biopharma R&D workforce (MassBio 2025 Industry Snapshot), and the Boston-Cambridge cluster represents nearly 13% of all U.S. life sciences R&D roles on its own (EPM Scientific, Boston Biotech Hub 2026). For roles as specialized as biostatistics, that concentration means recruiters are fishing in the same small pond as every direct competitor.
Where is life sciences hiring demand actually concentrated right now?
Rebounding, and increasingly focused on a specific set of functions. Biopharma R&D and clinical operations hiring rebounded in Q2 2026 with layoffs easing sharply — only 17 companies reported cuts versus 33 in Q1 2026 — with demand concentrated in R&D, clinical operations, regulatory affairs, manufacturing/quality, and AI/data science, especially around GLP-1, oncology, and cell and gene therapy programs (Biopharma Job Market Report Q2 2026, talk.bio). That concentration means generalist sourcing approaches increasingly miss the roles actually driving hiring volume.
Why is the industry losing biostatisticians and computational biologists to tech companies?
Because the same skill set that makes someone valuable to a biotech also makes them attractive to big tech, which is winning the compensation competition for scarce talent. Life sciences data scientist roles have grown 22% since 2022 and are nearly twice as concentrated in the industry as the national average, yet employers report "an acute shortage of trained biostatisticians and data scientists ... not being created enough by our institutions" — and when they are trained, "they're oftentimes migrating towards the tech sector, and away from the biotech sector" (TEConomy/InnovateBio 2025 Life Sciences Workforce Trends Report). This cross-industry competition for the same computational talent is precisely why biostatistics and regulatory postings remain the hardest reqs to close even as overall hiring difficulty eases from 2021-22 peaks.
How does specialist recruiting performance compare to the industry average fill time?
The gap between focused, technology-enabled sourcing and generalist recruiting is significant. One specialist recruiter benchmarking against industry data claims a 22-day average vacancy fill versus a 68-day industry average — illustrating the size of the speed advantage a focused, technology-enabled process can capture (Apsida Life Science) — a single-source LinkedIn benchmark that should be read as directional rather than independently verified, but consistent with the broader time-to-fill data documented across GForce and Hyper Recruitment Solutions. Separately, industry commentary has pegged the cost of a prolonged life-science vacancy at roughly $600 per day in lost productivity and program delay risk (LinkedIn/Bryan Blair analysis, April 2025) — also unverified as a single authoritative figure, but directionally consistent with GxP-role vacancy cost analyses elsewhere in the sector.
UPPER's POV
Biostatistics and regulatory affairs hiring is a search for people who don't just have the right degree — they have the right combination of technical depth, regulatory fluency, and, ideally, therapeutic-area context, and they're being actively recruited away from the industry entirely. UPPER's autonomous sourcing looks past the obvious hub markets and job-board listings to identify credentialed, currently-employed specialists — including adjacent-industry converts from diagnostics, medtech, and academic research — expanding a search radius that a single-metro, keyword-based process can't match.
Key data points
- Biostatistics postings stay open a 34-day median versus 20 days for general data science roles (PharmaPayWatch).
- Regulatory affairs and biostatistics remain the hardest-to-source functions, per HR leader surveys (TEConomy/InnovateBio).
- Life sciences data scientist roles grew 22% since 2022 (TEConomy/InnovateBio).
- Massachusetts holds 23% of the entire U.S. biopharma R&D workforce (MassBio 2025).
- Boston-Cambridge alone represents nearly 13% of all U.S. life sciences R&D roles (EPM Scientific).